Curcumin formulations for better bioavailability: what we learned from clinical trials thus far?

M Hegde, S Girisa, B BharathwajChetty, R Vishwa… - ACS …, 2023 - ACS Publications
Curcumin has been credited with a wide spectrum of pharmacological properties for the
prevention and treatment of several chronic diseases such as arthritis, autoimmune …

Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials

AB Kunnumakkara, M Hegde, D Parama… - ACS Pharmacology & …, 2023 - ACS Publications
Turmeric (Curcuma longa) has been used for thousands of years for the prevention and
treatment of various chronic diseases. Curcumin is just one of> 200 ingredients in turmeric …

Curcumin‐piperine co‐supplementation and human health: A comprehensive review of preclinical and clinical studies

H Heidari, M Bagherniya, M Majeed… - Phytotherapy …, 2023 - Wiley Online Library
Curcumin is extracted from the rhizomes Curcuma longa L. It is known for its anti‐
inflammatory and anti‐oxidant activities. Despite its safety and potential for use against …

Promising clinical outcomes of nano‐curcumin treatment as an adjunct therapy in hospitalized COVID‐19 patients: A randomized, double‐blinded, placebo‐controlled …

M Sadeghizadeh, E Asadollahi… - Phytotherapy …, 2023 - Wiley Online Library
Different immunomodulation strategies have been used to manage COVID‐19 due to the
complex immune‐inflammatory processes involved in the pathogenesis of this infection …

Curcumin for the treatment of COVID‐19 patients: a meta‐analysis of randomized controlled trials

A Shafiee, MMT Athar, A Shahid… - Phytotherapy …, 2023 - Wiley Online Library
Curcumin is a low‐cost and easily accessible therapeutic option for COVID‐19 patients. We
aimed to conduct a meta‐analysis to assess the effect of curcumin on clinical outcomes in …

Therapeutic potential of curcumin in ARDS and COVID‐19

MV Suresh, S Francis, S Aktay… - Clinical and …, 2023 - Wiley Online Library
Curcumin is a safe, non‐toxic, readily available and naturally occurring compound, an active
constituent of Curcuma longa (turmeric). Curcumin could potentially treat diseases, but faces …

[PDF][PDF] Curcumin as an antiviral agent and immune-inflammatory modulator in COVID-19: A scientometric analysis

K Liu, Y Zhu, X Cao, Y Liu, R Ying, Q Huang, P Gao… - Heliyon, 2023 - cell.com
Background Reports regarding the antiviral activity of curcumin have surfaced. However, to
date there has been no scientometric analysis of the relationship between curcumin and …

[HTML][HTML] Ethnomedicinal, Phytochemistry and Antiviral Potential of Turmeric (Curcuma longa)

BBL Srivastava, AS Ripanda, HM Mwanga - Compounds, 2022 - mdpi.com
Turmeric (Curcuma longa) has been a famous root crop for its medicinal properties since pre-
historical times. Lack of effective therapeutics for most viral diseases, higher cost of some …

The Efficacy of Herbs as Complementary and Alternative Therapy in Recovery and Clinical Outcome Among People with COVID-19: A Systematic Review, Meta …

M Komariah, S Amirah, S Maulana… - … and clinical risk …, 2023 - Taylor & Francis
Background The COVID-19 pandemic continues, and this condition has caused many cases
in various countries around the world, resulting in more than 6 million deaths worldwide …

Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A …

JE Levitt, H Hedlin, S Duong, D Lu, J Lee… - Clinical Infectious …, 2023 - academic.oup.com
Background The vast majority of coronavirus disease 2019 (COVID-19) disease occurs in
outpatients where treatment is limited to antivirals for high-risk subgroups. Acebilustat, a …